LPL Financial
ONCY

LPL Financial’s Oncolytics Biotech ONCY Stock Holding History

LPL Financial’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67K Buy
78,901
+38,483
+95% +$38.3K ﹤0.01% 5745
2025
Q4 		$35.3K Sell
40,418
-10,937
-21% -$11.8K ﹤0.01% 5742
2025
Q3 		$71.9K Buy
+51,355
New +$57.5K ﹤0.01% 5578
2025
Q2 		– Sell
-16,150
Closed -$8.88K – 5656
2025
Q1 		$8.88K Buy
16,150
+128
+0.8% +$94 ﹤0.01% 5321
2024
Q4 		$14.6K Sell
16,022
-4,500
-22% -$4.68K ﹤0.01% 5230
2024
Q3 		$17.9K Buy
20,522
+13
+0.1% +$13 ﹤0.01% 5093
2024
Q2 		$20.3K Buy
20,509
+2,500
+14% +$2.72K ﹤0.01% 4934
2024
Q1 		$19.1K Sell
18,009
-1,570
-8% -$1.75K ﹤0.01% 4846
2023
Q4 		$26.4K Sell
19,579
-2,000
-9% -$3.13K ﹤0.01% 4716
2023
Q3 		$47K Buy
+21,579
New +$52.7K ﹤0.01% 4525
2022
Q4 		– Sell
-16,512
Closed -$20K – 4528
2022
Q3 		$20K Hold
16,512
– – ﹤0.01% 4328
2022
Q2 		$17K Sell
16,512
-5,000
-23% -$6.08K ﹤0.01% 4353
2022
Q1 		$34K Buy
21,512
+1,000
+5% +$1.68K ﹤0.01% 4086
2021
Q4 		$29K Buy
20,512
+23
+0.1% +$43 ﹤0.01% 4271
2021
Q3 		$43K Buy
20,489
+8,529
+71% +$19.3K ﹤0.01% 4239
2021
Q2 		$33K Sell
11,960
-550
-4% -$1.69K ﹤0.01% 4171
2021
Q1 		$48K Buy
12,510
+1,000
+9% +$2.98K ﹤0.01% 3998
2020
Q4 		$27K Sell
11,510
-2,000
-15% -$4.79K ﹤0.01% 3769
2020
Q3 		$23K Hold
13,510
– – ﹤0.01% 3497
2020
Q2 		$25K Buy
+13,510
New +$25.4K ﹤0.01% 3397

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial's ONCY Position: Q1 2026 in Review

LPL Financial increased its Oncolytics Biotech (ONCY) stake by 95% in Q1 2026, buying an estimated $38.3K and bringing the position to 78,901 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #5745.

LPL Financial first reported a position in ONCY in Q2 2020 and has held it in 20 quarters since. The position peaked at $71.9K in Q3 2025. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • LPL Financial held 78,901 shares of Oncolytics Biotech worth $67K as of Q1 2026.
  • LPL Financial bought 38,483 Oncolytics Biotech shares in Q1 2026, an estimated $38.3K.
  • Oncolytics Biotech made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5745 holding.
  • LPL Financial first reported a position in Oncolytics Biotech in Q2 2020 and has held it in 20 quarters since.
  • LPL Financial's Oncolytics Biotech position peaked at $71.9K in Q3 2025.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.